REG - Inspiration Health - Board Change

Inspiration HealthcareAnnouncement

Yesterday 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250606:nRSF7090La&default-theme=true

RNS Number : 7090L  Inspiration Healthcare Group PLC  06 June 2025

 

6 June
2025

Inspiration Healthcare Group plc

 

("Inspiration Healthcare", the "Company" or the "Group")

 

Board Change

 

Inspiration Healthcare Group plc (AIM: IHC), the global medical technology
company pioneering best-in-class, specialist neonatal intensive care medical
devices, announces that Neil Campbell, non-executive director, has informed
the Board that he will not be seeking re-election at the Company's 2025 Annual
General Meeting and will formally step down from the Board on 24 July 2025 at
the end of the Board meeting scheduled to be held on that day. The Company
does not intend to replace this position but will instead keep the composition
of the Board under review.

 

Roy Davis, Chair, said:

 

"On behalf of myself and the Board, I would like to thank Neil for his
outstanding commitment and invaluable contribution to the Company over the
many years since its founding. He has taken the Company from inception to the
position it is today and ensured the smooth transition of leadership since
standing down as CEO last year. We wish Neil every success in his future
endeavours."

 

Neil Campbell, said:

 

"Having stepped down from being CEO last summer it has been a privilege to
have served on the Board as a non-executive director and help with the
transition to a new management team. However, with a new CEO in place and the
company moving forward, it is the right time for me to move on to new
challenges and support the Company as a shareholder. I would like to thank Roy
Davis, Chair, for giving me the opportunity to be a non-executive director and
wish the Company the very best for the future."

 

 

For further information, please contact:

 

 Inspiration Healthcare Group plc                  Tel: +44 (0)330 175 0000
 Raffi Stepanian, Chief Executive Officer

 Alan Olby, Chief Financial Officer

 Panmure Liberum (Nominated Adviser & Broker)      Tel: +44 (0)20 3100 2000
 Emma Earl

 Will Goode

 Walbrook PR Ltd (Media and Investor Relations)    Tel: +44 (0)20 7933 8780 or inspirationhealthcare@walbrookpr.com
                                                   (mailto:inspirationhealthcare@walbrookpr.com)
 Anna Dunphy                                       Mob: +44 (0) 7876 741 001

 

About Inspiration Healthcare

 

Inspiration Healthcare (AIM: IHC) designs, manufactures and markets pioneering
medical technology. Based in the UK, the Company specialises in neonatal
intensive care medical devices, which are addressing a critical need to help
to save the lives and improve the outcomes of patients, starting with the very
first breaths of life.

 

The Company has a broad portfolio of its own products and complementary
distributed products, for use in neonatal intensive care designed to support
even the most premature babies throughout their hospital stay. Its own branded
products range from highly sophisticated capital equipment such as ventilators
for life support through to single-use disposables.

 

The Company sells its products directly to hospitals and healthcare providers
in the UK and Ireland, where it also distributes a range of advanced medical
technologies for infusion therapy.  In the rest of the world the Company has
an established network of distribution partners around the world giving access
to more than 75 countries.

 

The Company operates in the UK from its Manufacturing and Technology Centre in
Croydon, South London, and in the USA from its facility in Melbourne, Florida.

 

Further information on Inspiration Healthcare can be found at
www.inspirationhealthcaregroup.com (http://www.inspirationhealthcaregroup.com)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOAFAMBTMTJMTIA